Portfolio

ACTIVE STUDIES RECRUITING: • M21-341 (AVANTI) – Hypothyroidism A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism. Those meeting the eligibility criteria will receive trial-related procedures [...]

ACTIVE STUDIES NON-RECRUITING: • CORT125134-452 – Open-Label Extension Trial For Cushing Syndrome An Open-Label Extension Study of the Safety of Relacorilant (CORT125134) in the Treatment of the Signs and Symptoms of Endogenous Cushing Syndrome. Those meeting the eligibility criteria will receive trial-related procedures and the study medication [...]

ACTIVE STUDIES RECRUITING: • 2V-MC-GZLF – Type 2 Diabetes / Obesity A Study to Investigate Weight Reduction with Macupatide and Eloralintide, Alone or in Combination, in Adult Participants with Obesity or Overweight and with Type 2 Diabetes. Those meeting the eligibility criteria will receive trial-related procedures and the study [...]

ACTIVE STUDIES RECRUITING: NO CURRENT ACTIVE STUDIES RECRUITING. PLEASE CHECK BACK AT A LATER DATE. ACTIVE STUDIES NON-RECRUITING: • J1I-MC-GZQA (TRANSCEND-T2D-3) – Kidney Disease / Type 2 Diabetes / Insulin The purpose of this study is to investigate the efficacy and safety of retatrutide compared [...]

ACTIVE STUDIES RECRUITING: • 20220196 (MARITIME-CV) – Cardiovascular Disease / Obesity(a) A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity. Those meeting the eligibility criteria will receive trial-related procedures [...]